The United States medical research landscape is currently facing a period of significant fiscal instability as Congress struggles to finalize…
The commencement of 2026 marks a pivotal moment for the global medical community as the Endocrine Society introduces its newest…
The study challenges traditional clinical thresholds that focus primarily on full-blown gestational diabetes mellitus (GDM). Instead, it highlights a spectrum…
NYU Langone Health has officially announced the appointment of Marcus D. Goncalves, MD, PhD, as the new director of the…
This landmark study, recently published in The Journal of Clinical Endocrinology & Metabolism, reveals a breakthrough in cardiovascular risk assessment…
The landscape of metabolic medicine underwent a significant transformation in early January 2026 as the 25 mg oral formulation of…
The United States Congress has finalized and passed a comprehensive funding bill for the Department of Health and Human Services…
The Endocrine Society has officially announced the commencement of its Rare Endocrine Disease (RED) Fellows Program, a comprehensive educational initiative…
In a landmark development for the treatment of type 2 diabetes and metabolic health, Eli Lilly and Company has announced…
The study provides a detailed roadmap of how semaglutide interacts with the tumor microenvironment (TME), specifically targeting immune cells known…
Amara Maple